US · MCI · ASSET MANAGEMENT
Barings Corporate Investors (MCI) intrinsic value and stock valuation
$16.30as of 2026-11-21 · Mkt cap 337.32M
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Barings Corporate Investors DCF and intrinsic value
InvestorsCraft values MCI with the Chepakovich two-stage DCF model — currently rated undervalued. How the model works · Run your own DCF prefilled from MCI’s statements →
Barings Corporate Investors Graham Number
Graham Number: $22.67d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2012–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Eagle Point Credit Company Inc. (ECC) $2.42
- Gladstone Capital Corporation (GLAD) $17.03
- BNY Mellon Strategic Municipals, Inc. (LEO) $5.69
- Source Capital, Inc. (SOR) $45.46
- Saratoga Investment Corp. (SAR) $10.74
- Palmer Square Capital BDC Inc. (PSBD) $9.50
- PennantPark Investment Corporation (PNNT) $2.71
- D. Boral ARC Acquisition I Corp. Cl A (BCAR) $4.72
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $32.7M | $43.3M | $41.2M | $28.7M | $55.5M |
| Operating income | $28.8M | $37.5M | $35.6M | $23.3M | $53.4M |
| Net income | $28.1M | $35.6M | $37M | $14.3M | $52.8M |
| EPSd | $1.37M | $1.75M | $1.82M | $709.8K | $2.6M |
| Operating cash flow | $18.6M | $28.1M | $32M | $3.92M | $2.83M |
| Capital expenditure | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Free cash flow | $18.6M | $28.1M | $32M | $3.92M | $2.83M |
| Total assets | $431.2M | $406.2M | $393.9M | $386.1M | $387.1M |
| Total debt | $74.7M | $45.9M | $42.3M | $46M | $38M |
| Net debt | $42.6M | $28.7M | $27.4M | $32.8M | $16.9M |
| Total equity | $341.3M | $343.6M | $339.8M | $331.6M | $338M |
| Cash and short-term investments | $32.1M | $17.2M | $14.9M | $13.2M | $21.2M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $32.7M | $43.3M | $41.2M | $28.7M | $55.5M |
| Cost of revenue | $2.57M | $1.78M | $0.00 | $1.71M | $1.07M |
| Gross profit | $30.2M | $37.9M | $41.2M | $28.7M | $54.5M |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $1.41M | $1.39M | $1.34M | $1.18M | $1.05M |
| Other expenses | $0.00 | $0.00 | $4.28M | $0.00 | $0.00 |
| Operating expenses | $1.41M | $1.39M | $5.62M | $1.18M | $1.05M |
| Cost and expenses | $3.97M | $5.75M | $5.62M | $5.35M | $5.22M |
| Interest income | $35.7M | $38.4M | $40.6M | $28.1M | $24.3M |
| Interest expense | $2.57M | $1.78M | $2.08M | $1.71M | $1.07M |
| Depreciation and amortization | -$-1.27M | -$-180K | -$-50K | $0.00 | $0.00 |
| Ebitda | $27.5M | $36.4M | $0.00 | $15M | $87.7M |
| Operating income | $28.8M | $37.5M | $35.6M | $23.3M | $53.4M |
| Total other income/expenses, net | $0.00 | -$-1.2M | $2.09M | -$-7.91M | $33.3M |
| Income before tax | $28.8M | $36.3M | $37.7M | $15.4M | $53.8M |
| Income tax expense | $710K | $760K | $710K | $1.15M | $990K |
| Net income | $28.1M | $35.6M | $37M | $14.3M | $52.8M |
| Weighted average shares outstanding | $20.5M | $20.3M | $20.3M | $20.1M | $20.3M |
| Weighted average diluted shares outstanding | $20.5M | $20.3M | $20.3M | $20.1M | $20.3M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $32.1M | $17.2M | $14.9M | $13.2M | $21.2M |
| Net receivables | $0.00 | $10.1M | $5.91M | $5.46M | $3.92M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current assets | $32.1M | $27.3M | $21.4M | $18.7M | $25.1M |
| Property, plant and equipment, net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Goodwill and intangible assets | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Long-term investments | $0.00 | $17M | $372.2M | $8.29M | $16.5M |
| Total non-current assets | $399.1M | $379M | $372.2M | $367.4M | $362M |
| Total assets | $431.2M | $406.2M | $393.9M | $386.1M | $387.1M |
| Accounts payable | $12.9M | $13.7M | $7.9M | $5.86M | $6.82M |
| Short-term debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $14.7M | $13.7M | $7.9M | $5.86M | $6.82M |
| Long-term debt | $74.7M | $45.9M | $42.3M | $46M | $38M |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $75.2M | $48.9M | $42.3M | $48.6M | $42.2M |
| Capital lease obligations | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total liabilities | $89.9M | $62.7M | $54.1M | $54.4M | $49.1M |
| Common stock | $20.5M | $20.4M | $20.3M | $20.3M | $20.3M |
| Retained earnings | $40.7M | $44.7M | $42.6M | $33.5M | $39.1M |
| Accumulated other comprehensive income (loss) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total equity | $341.3M | $343.6M | $339.8M | $331.6M | $338M |
| Total investments | $0.00 | $17M | $372.2M | $8.29M | $16.5M |
| Total debt | $74.7M | $45.9M | $42.3M | $46M | $38M |
| Net debt | $42.6M | $28.7M | $27.4M | $32.8M | $16.9M |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $28.1M | $35.6M | $37M | $14.3M | $52.8M |
| Depreciation and amortization | -$-1.27M | -$-180K | -$-50K | $0.00 | $0.00 |
| Stock-based compensation | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Change in working capital | -$-830K | -$-980K | $170K | -$-4.82M | $2.26M |
| Accounts receivable | -$-110K | -$-3.58M | -$-1.04M | -$-1.54M | -$-1.44M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts payable | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash provided by operating activities | $18.6M | $28.1M | $32M | $3.92M | $2.83M |
| Investments in property, plant and equipment | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acquisitions, net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for investing activities | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock issued | $2.45M | $2.56M | $0.00 | $0.00 | $0.00 |
| Common stock repurchased | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Dividends paid | -$-34.77M | -$-31.9M | -$-26.75M | -$-19.86M | -$-19.45M |
| Net cash used for financing activities | -$-3.64M | -$-25.8M | -$-30.38M | -$-11.84M | -$-11.53M |
| Net change in cash | $14.9M | $2.33M | $1.64M | -$-7.92M | -$-8.7M |
| Cash at end of period | $32.1M | $17.2M | $14.9M | $13.2M | $21.2M |
| Operating cash flow | $18.6M | $28.1M | $32M | $3.92M | $2.83M |
| Capital expenditure | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Free cash flow | $18.6M | $28.1M | $32M | $3.92M | $2.83M |
Line items
Line items
Line items
About Barings Corporate Investors
The Babson Capital Corporate Investors trust, which was previously identified simply as Babson Capital Corporate Investors, operates as a closed-end mutual fund focused on fixed-income investments. This entity, launched and managed by Barings LLC, primarily allocates capital within the United States' fixed-income markets. Its investment strategy targets securities from companies spanning various diversified sectors. A significant portion of its portfolio is dedicated to privately placed, long-term corporate debt obligations that are rated below investment grade. Additionally, the fund invests in marketable debt instruments, including those with investment-grade ratings, other publicly traded debt, and common stocks. Formed in 1971, the trust maintains its legal domicile in the United States.
- CEO
- Clifford Michael Noreen
- Employees
- 0
- Beta
- 0.31
Explore
Frequently asked questions
What is the intrinsic value of Barings Corporate Investors (MCI)?
Barings Corporate Investors (MCI) is currently undervalued based on the InvestorsCraft IC model — IC value is 20–50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is MCI undervalued?
MCI trades at a price of $16.30 (Nov 21, 2026): undervalued — IC value is 20–50% above the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.